Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02317744 · ClinicalTrials.gov registry record · NA
Treatment of Binge Eating Disorder in Obesity: Naltrexone/ Bupropion Combination Versus Placebo
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT02317744 is a NA study that has completed, run by Yale University. The registered enrollment target is 22 participants.
The verdict
NCT02317744, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
This study will test the effectiveness of the combination of Naltrexone and Bupropion relative to placebo for reducing binge eating in persons with obesity and binge eating disorder.
Interventions
- DRUG Naltrexone and bupropion combination
- OTHER Pill Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2014-12 |
| Est. Completion | 2016-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02317744
The ClinicalTrials.gov registry entry for NCT02317744 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Naltrexone and bupropion combination is the first listed.
NCT02317744 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02317744 about?
NCT02317744 is a clinical study titled "Treatment of Binge Eating Disorder in Obesity: Naltrexone/ Bupropion Combination Versus Placebo". This study will test the effectiveness of the combination of Naltrexone and Bupropion relative to placebo for reducing binge eating in persons with obesity and binge eating disorder.
What is the current status of trial NCT02317744?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2014-12. Estimated completion is 2016-09.
What interventions are being tested in trial NCT02317744?
The interventions under investigation include: Naltrexone and bupropion combination (DRUG), Pill Placebo (OTHER).
Who is sponsoring clinical trial NCT02317744?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.